Studies have shown that E-cadherin inhibits breast cancer cell proliferation, epithelial-mesenchymal transition (EMT) and metastasis by combining with β-catenin and reducing β-catenin transcriptional activation of the target gene cyclin D1 in the nucleus [14-16]. The gene discussed is CDH1; the disease is breast cancer.